Reduced hemostatic effects with drospirenone-based oral contraceptives containing ESTETROL (cas 15183-37-6) vs. ethinyl estradiol
-
Add time:08/03/2019 Source:sciencedirect.com
SummaryObjectiveThe effects of ESTETROL (cas 15183-37-6) (E4), a natural fetal estrogen, combined with drospirenone (DRSP) were evaluated on plasma levels of sex hormone-binding globulin (SHBG), angiotensinogen and 12 hemostasis markers.
We also recommend Trading Suppliers and Manufacturers of ESTETROL (cas 15183-37-6). Pls Click Website Link as below: cas 15183-37-6 suppliers
Prev:Effect of ESTETROL (cas 15183-37-6) on Beta-Endorphin level in female rats
Next:Whole blood microsampling for the quantitation of ESTETROL (cas 15183-37-6) without derivatization by liquid chromatography-tandem mass spectrometry) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Ovulation inhibition by ESTETROL (cas 15183-37-6) in an in vivo model08/05/2019
- Whole blood microsampling for the quantitation of ESTETROL (cas 15183-37-6) without derivatization by liquid chromatography-tandem mass spectrometry08/04/2019
- Effect of ESTETROL (cas 15183-37-6) on Beta-Endorphin level in female rats08/02/2019
- Effect of ESTETROL (cas 15183-37-6) administration on brain and serum allopregnanolone in intact and ovariectomized rats08/01/2019
- Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating ESTETROL (cas 15183-37-6) to prevent cerebral ischemia of premature babies07/31/2019
- Clinical applications for ESTETROL (cas 15183-37-6)07/30/2019
- Effect of ESTETROL (cas 15183-37-6), a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis07/29/2019
- Clinical effects of the fetal estrogen ESTETROL (cas 15183-37-6) in a multiple-rising-dose study in postmenopausal women07/28/2019
- Regulatory effects of ESTETROL (cas 15183-37-6) on the endothelial plasminogen pathway and endothelial cell migration07/27/2019